Form 4: Director Sells LMAT Shares After Option Exercise

A director at LEMAITRE VASCULAR INC exercised stock options and subsequently sold 2,500 shares of common stock as part of a pre-planned trading arrangement.

Summary

• Director Bridget A. Ross exercised 2,500 stock options for LEMAITRE VASCULAR INC common stock at a price of $37.29 per share on August 8, 2025.
• Immediately following the exercise, Ms. Ross sold all 2,500 shares of common stock at a price of $94 per share on August 8, 2025.
• The transactions were conducted under a Rule 10b5-1(c) pre-planned trading arrangement.
• Following these transactions, Ms. Ross directly beneficially owns 2,916 shares of LEMAITRE VASCULAR INC common stock.
• The exercised options were fully vested and exercisable as of December 2, 2020, and were set to expire on December 2, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an insider sale can be viewed negatively, the fact that it was a pre-planned exercise and sale under a 10b5-1 plan mitigates concerns about a lack of confidence. It represents a director monetizing vested compensation.

Positives

• The exercise of options indicates the director capitalized on vested equity, realizing a significant gain from the difference between the exercise price ($37.29) and the sale price ($94).
• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-planned and systematic approach to equity management rather than a reactive sale based on new information.

Negatives

• The sale of shares by a director, even if pre-planned, reduces insider ownership and could be perceived by some investors as a reduction in confidence in future stock price appreciation.

Future Outlook

No forward-looking statements or guidance are provided in this filing, as it pertains solely to an insider transaction.

Industry Context

This announcement is specific to an insider transaction and does not provide broader insights into industry trends or competitive landscape.

Stakeholder Impact

• Shareholders may interpret the director's sale as a signal, though the 10b5-1 plan suggests it's a routine liquidity event rather than a bearish signal.

Key Dates

Recommendation

The transaction represents a director exercising vested options and selling shares, which is a common occurrence for executive compensation. The presence of a Rule 10b5-1 plan indicates a pre-scheduled transaction, reducing the likelihood that it signals new negative information about the company. While it reduces insider ownership, it does not provide a strong basis for a 'buy' or 'sell' recommendation, suggesting a 'hold' position for existing investors.

Keywords

LEMAITRE VASCULAR INC, LMAT, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Director Transaction, Bridget A Ross, 10b5-1 Plan, Medical Devices